Physician profile
Eric Akin
NPI 1447220264
$2,359.57
in general payments reported to CMS, 2019-2025
13 companies · $54.52 in 2025
The $54.52 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,903 · 2020: $151 · 2021: $88.00 · 2022: $26.22 · 2023: $54.88 · 2024: $81.34 · 2025: $54.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,685.50 | 2019 | |
| Nevro Corp. | $133.63 | 2019-2022 | |
| Incyte Corporation | $100.74 | 2020 | |
| Si-Bone, INC. | $73.73 | 2019 | |
| Saluda Medical Americas, INC. | $62.33 | 2024 | Evoke |
| Gt Medical Technologies, INC | $54.52 | 2025 | Gammatile |
| Abbvie INC. | $47.44 | 2022-2024 | Botox |
| Portola Pharmaceuticals, LLC | $42.89 | 2019 | |
| Haemonetics Corporation | $39.30 | 2023 | Teg6s Hemostasis System |
| Integra Lifesciences Corporation | $37.58 | 2019 | |
| Stryker Corporation | $31.92 | 2020 | |
| Depuy Synthes Sales INC. | $26.14 | 2019 | |
| Supernus Pharmaceuticals, INC. | $23.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Akin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.